Shares of Invacare Co. (NYSE:IVC) have earned a consensus recommendation of “Hold” from the six research firms that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $16.50.

IVC has been the subject of a number of recent analyst reports. Zacks Investment Research raised shares of Invacare from a “sell” rating to a “hold” rating in a research report on Wednesday, January 31st. KeyCorp reissued a “buy” rating and set a $20.00 target price on shares of Invacare in a research report on Thursday, December 21st. Finally, ValuEngine raised shares of Invacare from a “sell” rating to a “hold” rating in a research report on Sunday, December 31st.

Shares of Invacare (NYSE IVC) opened at $18.35 on Tuesday. The firm has a market cap of $603.17, a P/E ratio of -7.84 and a beta of 2.54. The company has a current ratio of 2.10, a quick ratio of 1.54 and a debt-to-equity ratio of 0.57. Invacare has a 52-week low of $10.20 and a 52-week high of $19.05.

Invacare (NYSE:IVC) last released its earnings results on Wednesday, February 7th. The health services provider reported ($0.42) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.44) by $0.02. The business had revenue of $250.35 million during the quarter, compared to the consensus estimate of $241.07 million. Invacare had a negative net margin of 7.92% and a negative return on equity of 14.95%. The company’s revenue for the quarter was up 1.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.46) EPS. equities research analysts forecast that Invacare will post -1.16 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, January 16th. Shareholders of record on Thursday, January 4th were given a dividend of $0.0125 per share. This represents a $0.05 dividend on an annualized basis and a yield of 0.27%. The ex-dividend date was Wednesday, January 3rd. Invacare’s dividend payout ratio is presently -2.14%.

Several institutional investors have recently bought and sold shares of the business. EAM Investors LLC bought a new position in shares of Invacare during the 4th quarter worth approximately $2,153,000. AlphaOne Investment Services LLC boosted its holdings in shares of Invacare by 0.8% during the 4th quarter. AlphaOne Investment Services LLC now owns 460,289 shares of the health services provider’s stock worth $7,756,000 after buying an additional 3,532 shares in the last quarter. Eversept Partners LLC bought a new position in shares of Invacare during the 4th quarter worth approximately $1,640,000. Royce & Associates LP boosted its holdings in shares of Invacare by 11.4% during the 4th quarter. Royce & Associates LP now owns 1,574,733 shares of the health services provider’s stock worth $26,534,000 after buying an additional 160,564 shares in the last quarter. Finally, UBS Asset Management Americas Inc. bought a new position in shares of Invacare during the 4th quarter worth approximately $234,000.

WARNING: This piece of content was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece of content on another domain, it was copied illegally and republished in violation of international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2018/02/13/invacare-co-ivc-given-average-recommendation-of-hold-by-brokerages.html.

About Invacare

Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company’s geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific.

Receive News & Ratings for Invacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare and related companies with MarketBeat.com's FREE daily email newsletter.